Apellis Pharmaceuticals Inc (APLS)
24.27
-0.01
(-0.04%)
USD |
NASDAQ |
Mar 28, 16:00
24.28
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals Shareholders Equity (Quarterly): 228.54M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Macrogenics Inc | 116.06M |
| Salarius Pharmaceuticals Inc | 1.512M |
| Y-mAbs Therapeutics Inc | 92.00M |
| Akero Therapeutics Inc | 750.11M |
| Recursion Pharmaceuticals Inc | 1.035B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 885.05M |
| Total Liabilities (Quarterly) | 656.51M |
| Debt to Equity Ratio | 1.981 |
| Current Ratio | 4.253 |
| Net Debt Paydown Yield | -1.81% |